P

Inventor

BUZHANSKY LUDMILA

IL11 patents
⚠️ This page may combine multiple inventors who share the name “BUZHANSKY LUDMILA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD

3 patents
US11261230B2Mar 1, 2022

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD0 citations59
US10723780B2Jul 28, 2020

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD0 citations48
US10266579B2Apr 23, 2019

Synthetic somatostatin receptor ligands

TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD0 citations48

UNIV RAMOT

3 patents
US11285115B2Mar 29, 2022

Peptide-based hydrogel particles and uses thereof

UNIV RAMOT0 citations56
US11773060B2Oct 3, 2023

Method for synthesis of 9-cis-beta-carotene and formulations thereof

UNIV RAMOT0 citations55
US11142496B2Oct 12, 2021

Method for synthesis of 9-cis-beta-carotene and formulations thereof

UNIV RAMOT0 citations55

TECH INNOVATION MOMENTUM FUND (ISRAEL) LTD PARTNERSHIP

1 patent
US9610353B2Apr 4, 2017

Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof

TECH INNOVATION MOMENTUM FUND (ISRAEL) LTD PARTNERSHIP1 citations58

GAZIT EHUD

1 patent
US9096645B2Aug 4, 2015

Dipeptide analogs for treating conditions associated with amyloid fibril formation

GAZIT EHUD3 citations58

AVIV MORAN

1 patent
US9074095B2Jul 7, 2015

Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof

AVIV MORAN2 citations54

TECH INNOVATION MOMENTUM FUND ISRAEL LIMITED PARTNERSHIP

1 patent
US10245351B2Apr 2, 2019

Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof

TECH INNOVATION MOMENTUM FUND ISRAEL LIMITED PARTNERSHIP0 citations49

RAMOT AT TEL-AVIV UNIV LTD

1 patent
US9630989B2Apr 25, 2017

Dipeptide analogs for treating conditions associated with amyloid fibril formation

RAMOT AT TEL-AVIV UNIV LTD0 citations48